Skip to main content
CDC Website

TB

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010. Morbidity and Mortality Weekly Report. 59 (RR-5); 1-25, June 25, 2010

This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.

Collaborative Framework for Care and Control of Tuberculosis and Diabetes

WHO and The Union have developed a Collaborative Framework for Care and Control of Tuberculosis and Diabetes, which presents recommendations based on evidence from systematic reviews and a series of expert consultations. It outlines essential steps for coordinated action in three areas: (1) establishment of mechanisms for collaboration between national TB programmes and suitable counterparts responsible for care and control of diabetes; (2) improved detection and management of TB in patients with diabetes; (3) improved detection and management of diabetes in patients with TB.

Was this page helpful? Give Feedback